SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-121737
Filing Date
2023-11-29
Accepted
2023-11-29 06:00:15
Documents
5
Period of Report
2023-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2331664d1_6k.htm 6-K 17263
2 EXHIBIT 99.1 tm2331664d1_ex99-1.htm EX-99.1 928000
3 EXHIBIT 99.2 tm2331664d1_ex99-2.htm EX-99.2 227019
4 EXHIBIT 99.3 tm2331664d1_ex99-3.htm EX-99.3 46566
5 GRAPHIC tm2331664d1_ex99-3img001.jpg GRAPHIC 3716
  Complete submission text file 0001104659-23-121737.txt   1225103
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39179 | Film No.: 231448284
SIC: 2834 Pharmaceutical Preparations